China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.93 +0.12 (+4.27%)
As of: Sep 30, 2026 · 12:50 PM EDT

China SXT Pharmaceuticals, Inc. (SXTC) Operating Leases (2023 - 2026)

Updated

China SXT Pharmaceuticals (SXTC) recorded Operating Leases of $53,442 in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 53.7% from $115,419 a year earlier.

Analysis

China SXT Pharmaceuticals, Inc. (SXTC) Operating Leases (2023 - 2026) Analysis & Trends

Starting with fiscal Q4 2023, China SXT Pharmaceuticals' Operating Leases history includes 7 quarters.

  • Annual Operating Leases has declined for three straight fiscal years, with a three-year compound annual growth rate of -40.0% (FY2023 to FY2026).
  • Across earlier fiscal years, Operating Leases came in at $115,419 in FY2025 (-35.0%), $177,538 in FY2024 (-28.4%) and $247,961 in FY2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 53,442.00
Sep 30, 2025 85,161.00
Mar 31, 2025 115,419.00
Sep 30, 2024 182,667.00
Mar 31, 2024 177,538.00
Sep 30, 2023 204,937.00
Mar 31, 2023 247,961.00
API Access

China SXT Pharmaceuticals, Inc. Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SXTC&period=max&api_key=YOUR_API_KEY